Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Assays for Cardiac Troponins—Reply

Assays for Cardiac Troponins—Reply Letters 2. Sze WM, Shelley M, Held I, Mason M. Palliation of metastatic bone pain: fraction radiotherapy had poorer prognoses, perhaps reflecting single fraction versus multifraction radiotherapy—a systematic review of the the perception that single-fraction treatment should be re- randomised trials. Cochrane Database Syst Rev. 2004;2(2):CD004721. served for patients with limited life expectancy or poor per- 3. Elshaug AG, McWilliams JM, Landon BE. The value of low-value lists. JAMA. formance status. However, single-fraction treatment has sub- 2013;309(8):775-776. stantial benefits for patient-centric palliative care, including 4. Potosky AL, Riley GF, Lubitz JD, Mentnech RM, Kessler LG. Potential for greater quality of life and convenience, reduced travel time, cancer related health services research using a linked Medicare-tumor registry database. Med Care. 1993;31(8):732-748. and lower treatment costs. We were unable to differentiate complicated from uncom- 5. Brown ML, Riley GF, Schussler NBS, Etzioni R. Estimating health care costs related to cancer treatment from SEER-Medicare data. Med Care. plicated bone metastases (though sensitivity analyses to ad- 2002;40(8)(suppl):IV-104-IV-117. dress this limitation revealed similar results). In addition, Medi- 6. Fairchild A, Barnes E, Ghosh S, et al. International patterns of practice in care claims data cannot differentiate retreatment from palliative radiotherapy for painful bone metastases: http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png JAMA American Medical Association

Assays for Cardiac Troponins—Reply

de Lemos, James A.
JAMA , Volume 310 (14) – Oct 9, 2013
Download PDF
3 pages

Loading next page...
 
/lp/american-medical-association/assays-for-cardiac-troponins-reply-KEwohjjlRL

References (6)

Publisher
American Medical Association
Copyright
Copyright 2013 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.
ISSN
0098-7484
eISSN
1538-3598
DOI
10.1001/jama.2013.276782
pmid
24104377
Publisher site
See Article on Publisher Site

Abstract

Letters 2. Sze WM, Shelley M, Held I, Mason M. Palliation of metastatic bone pain: fraction radiotherapy had poorer prognoses, perhaps reflecting single fraction versus multifraction radiotherapy—a systematic review of the the perception that single-fraction treatment should be re- randomised trials. Cochrane Database Syst Rev. 2004;2(2):CD004721. served for patients with limited life expectancy or poor per- 3. Elshaug AG, McWilliams JM, Landon BE. The value of low-value lists. JAMA. formance status. However, single-fraction treatment has sub- 2013;309(8):775-776. stantial benefits for patient-centric palliative care, including 4. Potosky AL, Riley GF, Lubitz JD, Mentnech RM, Kessler LG. Potential for greater quality of life and convenience, reduced travel time, cancer related health services research using a linked Medicare-tumor registry database. Med Care. 1993;31(8):732-748. and lower treatment costs. We were unable to differentiate complicated from uncom- 5. Brown ML, Riley GF, Schussler NBS, Etzioni R. Estimating health care costs related to cancer treatment from SEER-Medicare data. Med Care. plicated bone metastases (though sensitivity analyses to ad- 2002;40(8)(suppl):IV-104-IV-117. dress this limitation revealed similar results). In addition, Medi- 6. Fairchild A, Barnes E, Ghosh S, et al. International patterns of practice in care claims data cannot differentiate retreatment from palliative radiotherapy for painful bone metastases:

Journal

JAMA – American Medical Association

Published: Oct 9, 2013

There are no references for this article.